All In Biotech

Drug Trial Radar · NCT02681055

Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects

An Open-Label Study To Evaluate The Efficacy, Safety, Tolerability and PK of MN-001 (Tipelukast) on HDL Function and Serum Triglyceride Levels in NASH and Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects With Hypertriglyceridemia

Last checked: Nov 19, 2026Latest source record: Mar 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

19

Actual

Start

Mar 2016

Primary completion

May 30, 2018

Study completion Oct 1, 2019

Sponsor

Lead sponsor
MediciNovaIndustry
Sponsor type
Industry
First posted
Feb 12, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, proof-of-principle, open-label study designed to evaluate the efficacy, safety, and tolerability of MN-001 in non-alcoholic steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) subjects with hypertriglyceridemia.

Conditions

  • Non-alcoholic Steatohepatitis
  • Hypertriglyceridemia
  • Non-alcoholic Fatty Liver Disease
  • Hypercholesterolemia

Interventions

  • MN-001Drug

    MN-001 is a novel, orally bioavailable small molecule compound which demonstrates anti-inflammatory activity

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change From Baseline at 12 Weeks of MN-001 Treatment on Cholesterol Efflux CapacityTime frame: Baseline, 12 weeks
  2. Mean Change From Baseline to Week 8 on Triglyceride Levels After 8 Weeks MN-001 TreatmentTime frame: 8 weeks

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Southern California Research Center

    Coronado, California

  • Scripps Research

    La Jolla, California

  • Harborview Medical Center

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.